Zika virus infection
Zika virus disease
measles vector Zika virus
measles vaccine vector
recombinant measles-Zika vaccine candidate
vaccine research
European Vaccine Initiative
affordable preventive vaccine
measles vector-based vaccines
rapid development
ZIKAVAX proposal
ultimate goal of ZIKAVAX
recent rapid spread
public health emergency
Fast track development
effective consortium
urgent public health issue
World Health Organization
preclinical track record of rapid adaptability
emerging mosquito
vaccines available
recent outbreak
infectious disease
Institute of Emerging Diseases
leading European organisations
adult volunteers
Innovative Therapies
Themis Bioscience GmbH
Institut Pasteur
demonstrated proof of principle
increase
humans
effectiveness
unaffected regions
strong epidemiological evidence
challenge model
delivery platform technology
severe congenital brain malformations of new-borns
Commissariat à l’Energie Atomique
phase Ia clinical trial
antigen selection
expression
demonstration of safety
immunogenicity
objective
mice
high yield
immunisation studies
specific treatments
non-human primates
purity
standard equipment
adults
neurological complications
manufacturing process
variety of pathogens
partners
flavivirus